[Syndrome of amenorrhea and galactorrhea. Clinical considerations]. / Sindrome de amenorréa y galactorréa. Consideraciones clínicas.
Ginecol Obstet Mex
; 41(247): 431-5, 1977 May.
Article
em Es
| MEDLINE
| ID: mdl-873276
PIP: Of 180 cases of secondary amenorrhea and 20 of primary amenorrhea, 46 patients suffered from the syndrome of amenorrhea and galactorrhea. This showed that this problem is more frequent than the literature indicates. Of the 46 cases, 13% had a pituitary tumor. Such a high percentage was found with several authors so the possibility of a tumor should always be considered. Another 24% of the cases were postpartum and 52.1% were idiopathic. The latter, suffering from primary or secondary sterility were treated with different ovulation induction medication and in 37.2% pregnancy resulted. In general, the treatment of amenorrhea and galactorrhea tries to restore normal ovulation and the menstrual cycle. Possible useful medications are clomiphene, citrate, pergonal, and levo-dopa. Also, recent studies indicate that some alkaloid derivitives of ergot are effective in treating the syndrome. It is important to realize that the syndrome may have physiopathogenic implications that substantiate careful ovulation induction medication.^ieng
Palavras-chave
Alkaloids; Amenorrhea--etiology; Central Nervous System Effects; Clomiphene; Diseases; Ergot Alkaloids--therapeutic use; Family Planning; Fertility Agents; Galactorrhea--etiology; Incidence; Ingredients And Chemicals; Measurement; Menstruation Disorders; Organic Chemicals; Puerperal Disorders; Reproductive Control Agents; Research Methodology
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Amenorreia
/
Galactorreia
/
Transtornos da Lactação
Limite:
Female
/
Humans
/
Pregnancy
Idioma:
Es
Revista:
Ginecol Obstet Mex
Ano de publicação:
1977
Tipo de documento:
Article
País de publicação:
México